Literature DB >> 6339405

Relative contribution of ColV plasmid and K1 antigen to the pathogenicity of Escherichia coli.

M E Agüero, F C Cabello.   

Abstract

To study the relevance of the ColV plasmid and the capsular K1 antigen in the pathogenicity of Escherichia coli, isogenic strains that differ only in these characteristics were constructed. Studies with these variants demonstrated that the presence of the ColV plasmid increased the serum resistance of E. coli. This increase did not depend on the expression of the K1 antigen. This work also demonstrated that the presence of the K1 antigen protects E. coli from the bactericidal activity of serum. Studies using mouse peritoneal macrophages in the presence of normal serum indicated that the presence of K1 antigen protects E. coli from phagocytosis. Similar experiments with the K1(+) strains performed in the presence of anti-K1 antibodies demonstrated that these antibodies opsonized these bacteria very efficiently in the absence of complement. The K1(-)E. coli variants were efficiently phagocytized in the presence of normal human serum and absorbed human serum, indicating that they are able to be opsonized by complement deposited by activation of the alternative pathway of complement. Work using fluorescence microscopy confirmed that the K1(-) strains are able to fix complement in the absence of antibody. It was also found that the presence of the ColV plasmid may interfere with phagocytosis of the E. coli K1 strains and deposition of complement on these cells. To test the relevance of the results of the in vitro experiments for disease, the pathogenicity of the strains was tested in mice. The results showed that the K1 antigen is the main determinant of pathogenicity of these strains and that the presence of ColV can modify the pathogenic potential of the E. coli K1 strains through a mechanism that does not depend on the production of colicin V.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339405      PMCID: PMC264856          DOI: 10.1128/iai.40.1.359-368.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity.

Authors:  P Stevens; S N Huang; W D Welch; L S Young
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  [Production of colicins V and V2 in vitro and in vivo. Study of their inhibitory action on phagocytosis by peritoneal macrophages].

Authors:  G Ozanne; L G Mathieu; J P Baril
Journal:  Rev Can Biol       Date:  1977-12

3.  Utilization of two distinct modes of replication by a hybrid plasmid constructed in vitro from separate replicons.

Authors:  K Timmis; F Cabello; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

4.  K-1 antigen of Escherichia coli: epidemiology and serum sensitivity of pathogenic strains.

Authors:  J Pitt
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

5.  Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.

Authors:  P K Peterson; Y Kim; B J Wilkinson; D Schmeling; A F Michael; P G Quie
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

6.  Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.

Authors:  B Björkstén; R Bortolussi; L Gothefors; P G Quie
Journal:  J Pediatr       Date:  1976-12       Impact factor: 4.406

7.  Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli.

Authors:  R J Gross; T Cheasty; B Rowe
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

8.  Epidemiology of Escherichia coli K1 in healthy and diseased newborns.

Authors:  L D Sarff; G H McCracken; M S Schiffer; M P Glode; J B Robbins; I Orskov; F Orskov
Journal:  Lancet       Date:  1975-05-17       Impact factor: 79.321

9.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.

Authors:  C Bianco; F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G.

Authors:  F M Griffin; C Bianco; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  17 in total

1.  Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1.

Authors:  P M Allen; I Roberts; G J Boulnois; J R Saunders; C A Hart
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

Review 2.  Complement resistance in microbes.

Authors:  M C Moffitt; M M Frank
Journal:  Springer Semin Immunopathol       Date:  1994

3.  A plasmid-encoded outer membrane protein, TraT, enhances resistance of Escherichia coli to phagocytosis.

Authors:  M E Agüero; L Aron; A G DeLuca; K N Timmis; F C Cabello
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

4.  Increased frequency of ColV plasmids and mannose-resistant hemagglutinating activity in an Escherichia coli K1 population.

Authors:  M E Agüero; H Harrison; F C Cabello
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

5.  Monoclonal antibody detection of IncF group plasmid-encoded TraT protein in clinical isolates of Escherichia coli.

Authors:  D Bitter-Suermann; H Peters; M Jürs; R Nehrbass; M Montenegro; K N Timmis
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

6.  ColV increases the virulence of Escherichia coli K1 strains in animal models of neonatal meningitis and urinary infection.

Authors:  M E Aguero; G de la Fuente; E Vivaldi; F Cabello
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

7.  TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity.

Authors:  T A Russo; M C Moffitt; C H Hammer; M M Frank
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Comparison of the antibacterial effect of uroepithelial cells from healthy donors and children with asymptomatic bacteriuria.

Authors:  H Schulte-Wissermann; W Mannhardt; J Schwarz; F Zepp; D Bitter-Suermann
Journal:  Eur J Pediatr       Date:  1985-09       Impact factor: 3.183

9.  Acquisition of genes from an O18:K1:H7 ColV+ strain of Escherichia coli renders intracranially-inoculated E. coli K12 highly virulent for chickens, ducks and guinea-pigs but not mice.

Authors:  H W Smith; M B Huggins
Journal:  J Hyg (Lond)       Date:  1985-10

10.  Survey of Escherichia coli septicemia over a six-year period.

Authors:  F Vázquez; M C Mendoza; G Viejo; F J Méndez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.